Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,708
Total Claims
$1.6M
Drug Cost
362
Beneficiaries
$4,376
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-84%
Opioid rate vs peers
0.4% vs 2.6% avg
+310%
Cost per patient vs peers
$4,376 vs $1,068 avg
+85%
Brand preference vs peers
16.7% vs 9.0% avg
Opioid Prescribing
0.4%
Opioid Rate
92
Opioid Claims
$1,186
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,781 claims · $1.2M
Generic: 18,882 claims · $376K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 804 | $275K |
| Bictegrav/Emtricit/Tenofov Ala | 25 | $102K |
| Sitagliptin Phosphate | 315 | $99K |
| Valbenazine Tosylate | 23 | $85K |
| Linagliptin | 264 | $77K |
| Apixaban | 224 | $68K |
| Paliperidone Palmitate | 15 | $47K |
| Rifaximin | 25 | $39K |
| Dolutegravir Sodium | 29 | $35K |
| Rivaroxaban | 100 | $32K |
| Emtricitabine/Tenofov Alafenam | 12 | $27K |
| Memantine Hcl | 442 | $25K |
| Lactulose | 884 | $19K |
| Atorvastatin Calcium | 1,666 | $19K |
| Sacubitril/Valsartan | 71 | $18K |
Prescribing Profile
Patient Profile
72
Avg Age
53%
Female
2.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data